| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| July 23rd, 2004 | 21 | Yes |
Popular Name: 4-Toluenesulfonyl-(3-trifluoromethylanilide) 4-Toluenesulfonyl-(3-trifluorome…
Find On: PubMed — Wikipedia — Google
CAS Numbers: , 1584-58-3
4-methyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide
4-Methyl-N-[3-(trifluoromethyl)phenyl]benzenesulphonamide
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 4.02 | 6 | -8.73 | 1 | 3 | 0 | 46 | 315.316 | 4 | ↓ |
| Mid Mid (pH 6-8) | 4.02 | 6.13 | -41.61 | 0 | 3 | -1 | 48 | 314.308 | 4 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| Purity | 95% | Fluorochem |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| CCNH-1-E | Cyclin H (cluster #1 Of 1), Eukaryotic | Eukaryotes | 400 | 0.43 | Binding ≤ 10μM |
| CDK7-1-E | Cyclin-dependent Kinase 7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 400 | 0.43 | Binding ≤ 10μM |
| MAT1-1-E | CDK-activating Kinase Assembly Factor MAT1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 400 | 0.43 | Binding ≤ 10μM |
| P90584-2-E | Protein Kinase Pfmrk (cluster #2 Of 2), Eukaryotic | Eukaryotes | 700 | 0.41 | Binding ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| MAT1_HUMAN | P51948 | CDK-activating Kinase Assembly Factor MAT1, Human | 400 | 0.43 | Binding ≤ 1μM |
| CCNH_HUMAN | P51946 | Cyclin H, Human | 400 | 0.43 | Binding ≤ 1μM |
| CDK7_HUMAN | P50613 | Cyclin-dependent Kinase 7, Human | 400 | 0.43 | Binding ≤ 1μM |
| P90584_PLAFA | P90584 | Protein Kinase Pfmrk, Plafa | 700 | 0.41 | Binding ≤ 1μM |
| MAT1_HUMAN | P51948 | CDK-activating Kinase Assembly Factor MAT1, Human | 400 | 0.43 | Binding ≤ 10μM |
| CCNH_HUMAN | P51946 | Cyclin H, Human | 400 | 0.43 | Binding ≤ 10μM |
| CDK7_HUMAN | P50613 | Cyclin-dependent Kinase 7, Human | 400 | 0.43 | Binding ≤ 10μM |
| P90584_PLAFA | P90584 | Protein Kinase Pfmrk, Plafa | 700 | 0.41 | Binding ≤ 10μM |
| Description | Species |
|---|---|
| Cyclin A/B1 associated events during G2/M transition | |
| Cyclin A:Cdk2-associated events at S phase entry | |
| Cyclin D associated events in G1 | |
| Cyclin E associated events during G1/S transition | |
| Dual incision reaction in GG-NER | |
| Dual incision reaction in TC-NER | |
| Formation of HIV elongation complex in the absence of HIV Tat | |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | |
| Formation of incision complex in GG-NER | |
| Formation of RNA Pol II elongation complex | |
| Formation of the Early Elongation Complex | |
| Formation of the HIV-1 Early Elongation Complex | |
| Formation of transcription-coupled NER (TC-NER) repair complex | |
| HIV Transcription Initiation | |
| mRNA Capping | |
| NoRC negatively regulates rRNA expression | |
| RNA Pol II CTD phosphorylation and interaction with CE | |
| RNA Polymerase I Chain Elongation | |
| RNA Polymerase I Promoter Escape | |
| RNA Polymerase I Transcription Initiation | |
| RNA Polymerase I Transcription Termination | |
| RNA Polymerase II HIV Promoter Escape | |
| RNA Polymerase II Pre-transcription Events | |
| RNA Polymerase II Promoter Escape | |
| RNA Polymerase II Transcription Elongation | |
| RNA Polymerase II Transcription Initiation | |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | |
| Tat-mediated elongation of the HIV-1 transcript | |
| Transcription of the HIV genome |
